Linda Burkly sold $2K of EDIT stock

Linda Burkly, EVP, Chief Scientific Officer of Editas Medicine, Inc. (EDIT), sold 731 shares of EDIT stock worth $2K, per an SEC Form 4 filed Jun 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 3, 2026, 2 days before it was made public.

EDIT has moved -14.4% since the trade date, from $2.78 to $2.38 (Nov 11, 2026 close).